Predicting the Need for an Implantable Cardioverter Defibrillator Using Cardiac Metaiodobenzylguanidine Activity Together with Plasma Natriuretic Peptide Concentration or Left Ventricular Function-Reference-Cited by-同舟云学术

Predicting the Need for an Implantable Cardioverter Defibrillator Using Cardiac Metaiodobenzylguanidine Activity Together with Plasma Natriuretic Peptide Concentration or Left Ventricular Function

Published:2008-01-16 Issue:2 Volume:49 Page:225-233
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Nagahara Daigo,Nakata Tomoaki,Hashimoto Akiyoshi,Wakabayashi Takeru,Kyuma Michifumi,Noda Ryosuke,Shimoshige Shinya,Uno Kikuya,Tsuchihashi Kazufumi,Shimamoto Kazuaki

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference31 articles.

1. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials

2. Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction

3. Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac sympathetic activity and lethal arrhythmic events: insight into bell-shaped relationship between 123I-meta-iodobenzylguanidine activity and event rates;EJNMMI Research;2024-07-21

2. Cardiac Imaging in Heart Failure;Handbook of Nuclear Cardiology;2024

3. Multimodality Imaging in the Diagnosis and Assessment of Cardiac Amyloidosis;World Journal of Nuclear Medicine;2022-08-16

4. Autonomic Innervation Evaluation in Cardiac Disease;International Journal of Cardiovascular Sciences;2021-06-30

5. 123I-mIBG in the Risk Stratification of Sudden Cardiac Death in Chronic Heart Failure;Nuclear Cardiology;2021